Disease | panic disorder |
Phenotype | C0041696|major depressive disorder |
Sentences | 15 |
PubMedID- 20663271 | A subtle grey-matter increase in first-episode, drug-naive major depressive disorder with panic disorder after 6 weeks' duloxetine therapy. |
PubMedID- 23037667 | Increases in amplitude of low-frequency fluctuations in left fronto-parietal area after duloxetine therapy in first-episode, drug-naive, major depressive disorder with panic disorder patients. |
PubMedID- 22137181 | Objective: we designed this study to investigate the changes of regional homogeneity (reho) after a 6-week duloxetine therapy in first-episode drug-naive major depressive disorder with panic disorder (femddpd) patients. |
PubMedID- 23037661 | Increased anterior cingulate regional homogeneity after duloxetine therapy in first-episode, drug-naive, major depressive disorder with panic disorder patients: a case series. |
PubMedID- 21926486 | Milnacipran in panic disorder with agoraphobia and major depressive disorder: a case report. |
PubMedID- 19833160 | Duloxetine related effects of brain structure on a patient of major depressive disorder with panic disorder. |
PubMedID- 21677224 | Duloxetine-related growth of putamen and brainstem in first-onset drug-naive major depressive disorder with panic disorder: a case series. |
PubMedID- 20599363 | First episode drug-naive major depressive disorder with panic disorder: gray matter deficits in limbic and default network structures. |
PubMedID- 20075662 | Duloxetine-modulating effects of brain structure in major depressive disorder with panic disorder. |
PubMedID- 23133615 | (2011) demonstrated that first-episode drug-naïve major depressive disorder with panic disorder patients displayed increased reho in the medial frontal cortex after short-term duloxetine therapy [45]. |
PubMedID- 21948903 | Duloxetine's effects in resting functional magnetic resonance imaging of first-episode, drug-naive major depressive disorder with panic disorder patients. |
PubMedID- 23861180 | Patient-reported outcomes of quality of life, functioning, and depressive symptom severity in major depressive disorder comorbid with panic disorder before and after ssri treatment in the star*d trial. |
PubMedID- 24860227 | She was diagnosed has having panic disorder with major depressive disorder. |
PubMedID- 24509652 | Structural alterations of the putamen, hippocampus, and thalamus might represent the structural pathophysiology of major depressive disorder comorbid with panic disorder. |
PubMedID- 22303519 | The search terms were bipolar disorder and major depressive disorder, cross-referenced with anxiety disorders/symptoms, panic disorder, agoraphobia, generalized anxiety disorder, social phobia, obsessive-compulsive disorder, and posttraumatic stress disorder. |
Page: 1